Acarix Wins UAE Approval for AI-Powered CADScor System
United Arab Emirates, August 10, 2026 Acarix AB has announced that its CADScorĀ® System, an artificial intelligence-enabled point-of-care diagnostic...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
United Arab Emirates, August 10, 2026 Acarix AB has announced that its CADScorĀ® System, an artificial intelligence-enabled point-of-care diagnostic...
SAN FRANCISCO, USA and SUZHOU, China, August 9, 2026 Innovent Biologics and Daiichi Sankyo have entered into an exclusive...
SOUTH SAN FRANCISCO, Calif., June 15, 2026 IDEAYA Biosciences has announced the initiation of a Phase 1/2 clinical combination...
TAMPA, Fla., June 15, 2026 TuHURA Biosciences, Inc. has announced the filing of an Investigational New Drug (IND) application...
